Back to HHLR ADVISORS, LTD. HHLR ADVISORS, LTD.

LYELLYEL
3 quarters

Position history for HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.'s holdings in LYELL IMMUNOPHARMA INC

HHLR ADVISORS, LTD. previously held 0 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $0 as of 2021-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$38.1M

Total Shares Change

-2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q4
Latest
Exited
0
-100.0%
$00.0%$151.00
0
2021-Q3
Unchanged
2.3M
0.0%
$34.8M0.5%$291.20
0
2021-Q2
New
2.3M
-
$38.1M0.4%$326.40
48

Other major holders of LYEL: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used